SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-003629
Filing Date
2023-01-13
Accepted
2023-01-13 08:30:17
Documents
13
Period of Report
2023-01-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm233354d1_8k.htm   iXBRL 8-K 43117
2 EXHIBIT 10.1 tm233354d1_ex10-1.htm EX-10.1 126505
  Complete submission text file 0001104659-23-003629.txt   375885

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idra-20230112.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20230112_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20230112_pre.xml EX-101.PRE 22601
7 EXTRACTED XBRL INSTANCE DOCUMENT tm233354d1_8k_htm.xml XML 3611
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 23527338
SIC: 2836 Biological Products, (No Diagnostic Substances)